復銳醫療(01696.HK)附屬擬斥3.1億人民幣購復星牙科
復銳醫療(01696.HK)簽訂買賣協議,全資附屬復銳醫療天津,向復星醫藥及復星醫藥的全資附屬天津謙達,收購復星牙科各自95%及5%權益,作價3.12億元人民幣。
復星牙科主要在中國從事進口及分銷海外牙科設備。
公司認為建議收購事項將使公司能夠透過將復星牙科的牙科專長整合到集團的美容知識技巧和設計能力中,來增強集團的醫療美容技術;透過利用復星牙科在中國的進口及分銷能力,以擴展集團的分銷網絡及產品提供;及探索交叉銷售的機會。
另外,公司目前上市所得資金仍有3.6億元未動用款項,考慮到較低的銀行存款利率以及集團最近的企業行動,公司擬使用未動用所得款項淨額支付建議收購事項的代價,代價的剩餘部分將由公司的內部現金資源結算。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.